Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma. - Wikidata - wikimedia - TriplyDB

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q34104724

about

PEA1 PEA2 PEO1 PEO14 PEO23 PEO4 PEO6

P1343

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer Phylogenetic quantification of intra-tumour heterogeneity Evolution of pre-existing versus acquired resistance to platinum drugs and PARP inhibitors in BRCA-associated cancers A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples.Modeling platinum sensitive and resistant high-grade serous ovarian cancer: development and applications of experimental systems.Discrete mixture modeling to address genetic heterogeneity in time-to-event regression Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.The NF1 somatic mutational landscape in sporadic human cancers.VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation.Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy.Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer NCI Workshop Report: Clinical and Computational Requirements for Correlating Imaging Phenotypes with Genomics Signatures Expression profile of COL2A1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer.Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells Translational application of epigenetic alterations: ovarian cancer as a model.HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.Two novel determinants of etoposide resistance in small cell lung cancer.Temporal dissection of tumorigenesis in primary cancers Insight into the heterogeneity of breast cancer through next-generation sequencing.Future medical applications of single-cell sequencing in cancer.DNA-PK mediates AKT activation and apoptosis inhibition in clinically acquired platinum resistance.Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patients Intra-tumor heterogeneity in TP53 null High Grade Serous Ovarian Carcinoma progression Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium.Rethinking ovarian cancer: recommendations for improving outcomes.MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib.Association between the cytogenetic profile of tumor cells and response to preoperative radiochemotherapy in locally advanced rectal cancer.Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer Empirical chemosensitivity testing in a spheroid model of ovarian cancer using a microfluidics-based multiplex platform.Mathematical models of breast and ovarian cancers.

P2860

Q54946892-DF755A14-E6D9-4453-B25F-212BCE447389 Q54946893-3AF72A23-73E5-4B4F-B7D0-06744D9EB783 Q54947162-E48AC2AC-7CC9-4931-A287-3163F721FEB9 Q54947165-46B3FAC2-0A68-40AA-B4A8-3F7717FEED52 Q54947167-97F8C0D4-6E91-4915-8C01-20009BA9427C Q54947168-02F9F0B5-A932-4CAF-86AE-6DF57D3D6A23 Q54947169-A8D64E02-A8AE-4837-B09D-FF0D21F5B85E

P1343

Q26740622-36512713-EA96-4A68-B5EB-E9366112CAE6 Q26780387-9090B241-41A9-4770-9F37-A221CA810F95 Q28537974-E96FC15D-7EED-4C10-BF47-64F393320377 Q28542563-ADB14F54-CBCA-4029-8D13-E9ECFD822808 Q28611264-F3AEAEFE-8194-44F5-A688-8B942C8E7033 Q28649475-D47150E1-600E-4FA4-BB3A-A6DABF361BF1 Q28740547-F76633E7-75A8-4302-A078-0886466ECD62 Q33554192-EEE323D4-44AB-4B0D-AF4C-B6151986E913 Q33574500-4036A5E8-32A6-4DFD-BAE1-24485167B4A3 Q33641924-814A5E1F-7CE0-4011-B32D-D9DC8F2A79EC Q33760422-DD48482C-58F5-40D9-8095-D3F0076AE03E Q33816983-85E935D0-C28B-4343-90F3-71138471DCD6 Q33823452-B8A23C06-53D1-441B-A492-8081281FC77B Q33891251-34559753-EA92-4F75-B9AB-F8C37B217A88 Q33930051-D76F4778-E145-44EB-9EE4-41EFA982EFAC Q33979826-9992502D-8B8D-4215-8E56-C2905FEEDA0A Q34274053-7ADC1294-BE46-4E97-B627-08E7A19E4F5C Q34285363-9B89412F-7E73-46C0-8D32-87E4CCBDA4FE Q34397197-F6730E66-3475-4990-B98F-0389F284E168 Q34478588-BBF3FE37-24A1-4DF7-B696-13A4B1F5FF3D Q34491120-26E0A4D3-409D-4604-AD92-C559431E7547 Q34543718-4F06E743-9AEE-4999-8BE1-7A073F9230DA Q34956879-D7DE05E0-9C62-406B-9D3D-2FB39336DF27 Q35085782-1D635127-A9A6-4942-A6B2-1B8882CE1C47 Q35087685-C4333F97-976F-4025-8DD1-AC7F57177E9A Q35132390-C4B1AE4E-4402-4483-9C5B-CB5F49344C01 Q35275682-AB660B9B-85CF-4790-81F2-BB2A05D7C8C4 Q35370090-E154AFAD-2322-47B7-9012-38C4363B89D6 Q35558519-6F2A18AC-CAA9-43ED-A582-8D329F3B4C2D Q35571896-8348DDD7-895B-4751-9C0E-42BB12477E6A Q35744147-6A9FEA88-9D0B-449B-A865-999B3F44760F Q35856294-421AFFDD-84CF-414E-B0C1-A824A87D9B9C Q36043441-4A99D4D7-76C5-4A60-8670-EC1138C86F43 Q36050883-69D617B2-D867-49D2-9E42-C31E5796510A Q36087979-851392F1-114B-4B6E-9B23-1D00B97E4285 Q36193815-E01F7D87-F328-4B69-9369-E9E95A808C22 Q36412660-58B3DC6D-BBF4-4FF6-86DF-ECF24B0C6573 Q36472419-A19340F2-77A1-4A45-9BD9-3B1B7D3AD8A3 Q36564821-324BFAB9-773F-4D5D-B501-1AE4CF9DCA60 Q37014152-4F77E5ED-BA7B-44C9-AD3E-E793D530EC07

P2860

Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma.

http://www.wikidata.org/entity/Q34104724

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@ast

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@en

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@nl

type

label

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@ast

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@en

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@nl

prefLabel

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@ast

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@en

Genomic analysis of genetic he ...... rade serous ovarian carcinoma.

@nl

P1433

Q34104724-211653BF-2B8A-43AF-BABB-CC5AD6B72677

P1476

Q34104724-8370B764-1855-418D-9905-8EC64D6152B1

P2093

Q34104724-202A0281-4DCB-41E8-AD0E-761DE9B9EEEA

Q34104724-3BDB68BD-624D-48F3-A338-681DD2A5E720

Q34104724-B9D538EC-5C43-4C9A-868A-A614E0296443

Q34104724-BE7E9006-11E3-48A0-A127-BACFAC8A672E

Q34104724-EE69E93B-6927-4461-95EF-823D2CA4A078

P2860

Q34104724-00F35D76-3BFD-4462-B25E-92CB7DC9C14C

Q34104724-058C1F10-B2A5-46B0-BCDD-B08A8502DB5A

Q34104724-0D36DA3A-52C3-40D2-B4AA-8ABBDD348795

Q34104724-131BBCFB-C1FE-41E1-8D20-A49A1647F83D

Q34104724-1A6EF78C-616D-4E7B-987F-C8F1AE9C647A

Q34104724-1D356B91-8516-4E26-9409-1D5C39B5B2D3

Q34104724-1FD47A18-B2C7-47C2-963B-E4BA9CF42BEA

Q34104724-29C9299F-9B13-4A2F-8186-EE0F4E86AE16

Q34104724-393C4B39-E8B0-4786-ADBE-B4BE304A6610

Q34104724-3AEC09D5-3404-4519-84D2-2679ED7D24A1

P2888

Q34104724-4F9669AB-7A29-4FB6-BB1D-C6733F4A4287

P304

Q34104724-83C4013C-A816-4A7C-BD0D-E0A75B6E6A95

P31

Q34104724-DAF9720F-40AE-4CB0-B173-9F8F37AA00C6

P356

Q34104724-1C41F9C8-B5BC-4AF4-B07A-D399DBB0188D

P407

Q34104724-6DB272BB-BEAE-46E7-A804-341497F8DAA0

P433

Q34104724-744E4746-6951-46ED-869D-69EFB38769A9

P4510

Q34104724-0FB2A6ED-20C0-4AAC-9D71-CD51B874E278

Q34104724-19F7953A-3984-4A2F-A038-BFF1C1FB9CAC

Q34104724-30DCC570-6140-4CB0-AA66-56594B25EA4C

Q34104724-56BA5AA7-0C2F-4E65-A8F0-4F67C9659D8C

Q34104724-A5117DE4-18C4-4E55-BF6F-56858240FBC9

Q34104724-A54120D0-A356-4D42-B898-9A9323581E9F

Q34104724-D03F3058-2EC1-45C3-AB84-5D86A38F73ED

P478

Q34104724-A11EC7BD-303B-4F70-A3AC-049A017FF26C

P50

Q34104724-010FFD71-F845-478C-AD7E-CB413EB629FD

Q34104724-48071175-638B-4D4E-96BF-A9217171ABA8

Q34104724-8FF1B295-E845-4948-864C-F42DF0933725

Q34104724-97D76C94-49BE-43CF-BF54-BD4A47823D24

P577

Q34104724-6F5F27CF-FA05-4B2E-9C56-8C7A80121DB4

P5875

Q34104724-3E9D9034-F966-4660-AD4E-C7DA459A948C

P6179

Q34104724-35406C46-3AC4-461B-8939-398C4560E4ED

P698

Q34104724-65489A9C-4A7C-41BB-91F5-A6C1B36F5C66

P921

Q34104724-30B2B418-A70F-45BD-A5EE-C043190ED4DB

P932

Q34104724-CC675D33-538B-42DE-B386-9FD115AE11A3

P356

P1433

P1476

Genomic analysis of genetic he ...... grade serous ovarian carcinoma

@en

P2093

D Huntsman

http://www.w3.org/2001/XMLSchema#string

J Temple

http://www.w3.org/2001/XMLSchema#string

N Melnyk

http://www.w3.org/2001/XMLSchema#string

S L Cooke

http://www.w3.org/2001/XMLSchema#string

S Langdon

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer as an evolutionary and ecological process

The Hallmarks of Cancer

Identification and cloning of human G-protein gamma 7, down-regulated in pancreatic cancer

WWOX: a candidate tumor suppressor gene involved in multiple tumor types

A cell cycle regulator potentially involved in genesis of many tumor types

The clonal evolution of tumor cell populations

A multigenic program mediating breast cancer metastasis to bone

Hallmarks of 'BRCAness' in sporadic cancers

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

Characterization of three new serous epithelial ovarian cancer cell lines.

P2888

P304

4905-4913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2010.245

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P4510

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

James D Brenton

Thomas J Hardcastle

Charlotte K Y Ng

Maria Jose Garcia

P577

2010-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44803633

http://www.w3.org/2001/XMLSchema#string

P6179

1012708027

http://www.w3.org/2001/XMLSchema#string

P698

20581869

http://www.w3.org/2001/XMLSchema#string

P921

P932

2933510

http://www.w3.org/2001/XMLSchema#string